Non-cystic Fibrosis Bronchiectasis
📧 Sign up to get email alerts when something new happens for Non-cystic Fibrosis Bronchiectasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis [NA]
This clinical trial evaluates the long-term use of the SIMEOX device at home for non-cystic fibrosis bronchiectasis. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis [Phase 2]
A Phase 2 proof-of-concept trial evaluating Itepekimab, an anti-IL-33 monoclonal antibody, for efficacy, safety and tolerability in non-cyst…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis [Phase 4]
Phase 4 trial update reporting the completion of a study evaluating Trikafta (elexacaftor/tezacaftor/ivacaftor) for non-cystic fibrosis bron…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection [Phase 2]
This completed Phase 2 trial evaluated inhaled AP-PA02 for safety, phage kinetics, and efficacy in non-cystic fibrosis bronchiectasis with c…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 3]
Phase 3 trial of Brensocatib in Non-Cystic Fibrosis Bronchiectasis completed; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough [Phase 2]
ARINA-1 was evaluated in a 28-day Phase 2a investigational-use trial for non-cystic fibrosis bronchiectasis with excess mucus and cough, and…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of benralizumab for non-cystic fibrosis bronchiectasis was terminated; results have been po…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis [NA]
A completed clinical trial evaluating the impact of support groups on patients with non-cystic fibrosis bronchiectasis.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
The document provides an update on a completed clinical trial studying nutritional status and intake in patients with non-cystic fibrosis br…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH [NA]
A completed clinical trial comparing at-home Simeox therapy to standard care in patients with non-cystic fibrosis bronchiectasis and chronic…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Roflumilast in Non-CF Bronchiectasis Study (2019) [Phase 2]
Phase 2 study of roflumilast for non-cystic fibrosis bronchiectasis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation [Phase 1]
Phase 1 study evaluating tolerability of BI 1323495 across dose cohorts and its impact on inflammatory biomarkers in non-cystic fibrosis bro…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis [Phase 2]
Phase 2 study evaluating HSK31858 in participants with non-cystic fibrosis bronchiectasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life [NA]
This is an update on a completed clinical trial evaluating the effect of a probiotic supplement on quality of life in chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. [Phase 3]
Phase 3 trial in non-cystic fibrosis bronchiectasis evaluating colistimethate sodium was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) [Phase 3]
Phase 3 trial update on inhaled CMS for non-cystic fibrosis bronchiectasis with chronic Pseudomonas aeruginosa infection assessing efficacy …
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 2]
Phase 2 trial assessing INS1007 in non-cystic fibrosis bronchiectasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) [Phase 3]
A Phase 3 study evaluating ciprofloxacin dispersion for inhalation in non-Cystic Fibrosis bronchiectasis has completed; results are not prov…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) [Phase 3]
Phase 3 trial of ciprofloxacin dispersion for inhalation in non-CF bronchiectasis completed.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection [Phase 2]
Phase 2 dose-finding trial evaluating tobramycin inhalation powder for non-cystic fibrosis bronchiectasis with Pseudomonas aeruginosa; study…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: The Role of Vitamin D3 in Pediatric Bronchiectasis Severity [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the role of Vitamin D3 in pediatric bronchiectasis severity, including cystic fibrosis and non-CF bronch…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis [Phase 2]
Phase 2 trial investigating inhaled ultra-low doses of melphalan for non-cystic fibrosis bronchiectasis.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis [Phase 2, Phase 3]
Phase 2/3 clinical trial update for inhaled nebulized tobramycin in non-CF bronchiectasis.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Roflumilast in Non-CF Bronchiectasis Study [Phase 2]
Phase 2 trial update for roflumilast in non-cystic fibrosis bronchiectasis has completed.